Fate Therapeutics, Inc. v. Shoreline Biosciences, Inc.
Opinion
1 2 3 4 5 6 7 10 11 FATE THERAPEUTICS, INC.; and Case No.: 22-cv-00676-H-MSB WHITEHEAD INSTITUTE FOR 12 BIOMEDICAL RESEARCH, ORDER: 13 Plaintiffs, (1) GRANTING DEFENDANTS’ 14 v. MOTIONS TO FILE DOCUMENTS 15 UNDER SEAL; SHORELINE BIOSCIENCES, INC.; and
[Doc. Nos. 119, 122, 125, 138.] 17 Defendants. (2) DIRECTING THE CLERK TO 18 FILE THE PROPOSED 19 DOCUMENTS UNDER SEAL ; AND 20
21 [Doc. Nos. 120, 123, 126, 139.]
22 (3) ORDERING DEFENDANT 23 KAUFMAN TO PUBLICLY FILE DOCKET ENTRY NO. 140 24
25 On January 27, 2023, Defendant Shoreline Biosciences, Inc. (“Shoreline”) filed a 26 motion to partially dismiss Plaintiffs’ first amended complaint pursuant to Federal Rule of 27 Civil Procedure 12(b)(6) for failure to state a claim. (Doc. No. 121.) On January 27, 2023, 28 Shoreline also filed a motion to file under seal portions of its motion to dismiss pursuant 1 to Civil Local Rule 79.2 and Patent Local Rule 2.2. (Doc. No. 119.) Specifically, Shoreline 2 requests to file under seal portions of its memorandum of points and authorities in support 3 of its motion to dismiss. (Id. at 1.) 4 On January 27, 2023, Shoreline filed an answer and counterclaims to Plaintiffs’ first 5 amended complaint. (Doc. No. 124.) On January 27, 2023, Shoreline also filed a motion 6 to file under seal portions of its answer and counterclaims pursuant to Civil Local Rule 7 79.2 and Patent Local Rule 2.2. (Doc. No. 122.) Specifically, Shoreline requests to file 8 under seal: (1) portions of its answer and counterclaims to Plaintiff’s first amended 9 complaint; and (2) exhibit T to the answer and counterclaims. (Id. at 1-2.) 10 On January 27, 2023, Shoreline filed a motion for partial summary judgment. (Doc. 11 No. 127.) On January 27, 2023, Shoreline also filed a motion to file under seal certain 12 document filed in connection with its motion for summary judgment pursuant to Civil 13 Local Rule 79.2 and Patent Local Rule 2.2. (Doc. No. 125.) Specifically, Shoreline 14 requests to file under seal: (1) portions of its motion for summary judgment; (2) Exhibit B 15 to the declaration of Dr. Ahmadian; and (3) Exhibit N to the Lonza declaration. (Id. at 1.) 16 In its three motions, Shoreline seeks to seal the documents at issue because they 17 either contain confidential information concerning the identities of three of Shoreline’s 18 four iPSC suppliers; or (2) references to third-party confidential information. (Doc. No. 19 119 at 1; Doc. No. 122 at 1-2; Doc. No. 125 at 2.) Shoreline argues, therefore, that 20 compelling reasons exist to seal the documents or portions of the documents at issue 21 because the public disclosure of this confidential information might harm Shoreline’s or 22 the third party’s competitive standing. (See Doc. No. 122 at 1; Doc. No. 125 at 1-3 (citing 23 Kamakana v. City & Cnty. of Honolulu, 447 F.3d 1172, 1178 (9th Cir. 2006); Mezzadri v. 24 Med. Depot, Inc., No. 14-CV-2330-AJB-DHB, 2015 WL 12564223, at *2 (S.D. Cal. Dec. 25 18, 2015); Baker v. SeaWorld Ent., Inc., No. 14CV2129-MMA (AGS), 2017 WL 5029612, 26 at *5–6 (S.D. Cal. Nov. 3, 2017); Icon-IP Pty Ltd. v. Specialized Bicycle Components, 27 Inc., No. 12-CV-03844-JST, 2015 WL 984121, at *2-3 (N.D. Cal. Mar. 4, 2015); Doe v. 28 Camp Pendleton & Quantico Hous. LLC, No. 20-CV-224-GPC-AHG, 2020 WL 1890576, 1 at *3 n.1 (S.D. Cal. Apr. 16, 2020)).) 2 On January 31, 2023, Defendant Dan S. Kaufman filed an answer and counterclaims 3 to Plaintiffs’ first amended complaint. (Doc. No. 137.) On January 31, 2023, Kaufman 4 also filed a motion to file under seal portions of its answer and counterclaims pursuant to 5 Civil Local Rule 79.2 and Patent Local Rule 2.2. (Doc. No. 138.) Kaufman seeks to seal 6 these portions of the document at issue because they contain confidential information 7 concerning negotiations between Plaintiffs and Kaufman and communications concerning 8 a patent license. (Id. at 1.) Kaufman argues, therefore, that compelling reasons exist to 9 seal these portions of the document at issue. (Id. (citing Doc. No. 111 at 2).) 10 After reviewing the documents at issue, the Court concludes that compelling reasons 11 exist to seal the documents. See Kamakana, 447 F.3d at 1179; Mezzadri, 2015 WL 12 12564223, at *2–3; Baker, 2017 WL 5029612, at *5–6; Doe, 2020 WL 1890576, at *3 n.1. 13 (See Doc. No. 111 at 2.) Further, where appropriate, Defendants have filed redacted 14 versions of the documents ensuring that their requests to seal are narrowly tailored to only 15 seal the confidential information at issue. See Doe v. L. Offs. of Winn & Sims, No. 06- 16 CV-00599-H-AJB, 2021 WL 2662311, at *1 (S.D. Cal. June 29, 2021) (“‘[A]ny order 17 sealing documents should be “narrowly tailored”’ to serve those compelling reasons.” 18 (quoting Ervine v. Warden, 214 F. Supp. 3d 917, 919 (E.D. Cal. 2016))); Whitewater W. 19 Indus., Ltd. v. Pac. Surf Designs, Inc., No. 317CV01118BENBLM, 2018 WL 3055938, at 20 *3 (S.D. Cal. June 14, 2018) (“Requests to seal must be narrowly tailored.”). As such, the 21 Court grants Defendants’ requests to file the documents under seal without prejudice to the 22 Court modifying this order at a later time or using the information in a written order. The 23 Court reserves the right to unseal all or some of the pleadings as appropriate under the law. 24 The Court directs the Clerk to file the proposed documents under seal. (Doc. Nos. 120, 25 123, 126, 139.) 26 The Court notes that on January 31, 2023, along with his motion to file under seal 27 and his sealed lodgment containing his unredacted answer and counterclaims, Defendant 28 Kaufman filed an additional sealed lodgment containing a certificate of service. (See Doc. 1 ||No. 140.) Kaufman did not move to seal this document, and compelling reasons do not 2 || exist to seal the certificate of service. Further, the filing of the certificate of service under 3 ||seal appears to be an error. As such, the Court declines to seal the certificate of service 4 ||(Doc. No. 140), and the Court orders Kaufman to publicly file the certificate of service 5 || within seven (7) days from the date this order is filed. 7 || DATED: February 1, 2023 | | | | | 8 MARILYN ®. HUFF, Distri ge 9 UNITED STATES DISTRICT COURT 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28
Free access — add to your briefcase to read the full text and ask questions with AI
Fate Therapeutics, Inc. v. Shoreline Biosciences, Inc. (Fate Therapeutics, Inc. v. Shoreline Biosciences, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.